Publications by authors named "Philipp Koehler"

Claim this Profile
M
Mortality of pneumonia in intensive care units: a post-hoc analysis of an international multicenter study by ESGCIP and EFISG.
Daniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, Erika Asperges, Lorenzo Ball, Philipp Koehler

Ann Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential serum galactomannan as outcome marker for invasive aspergillosis - an exploratory study from the FungiScope® registry.
Christina Többen, Oliver A Cornely, Carolin S Joisten, Ertan Sal, José A Cozzi, Philipp Koehler

Int J Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.
Johan A Maertens, George R Thompson, Andrej Spec, Fariba M Donovan, Sarah P Hammond, Philipp Koehler

Lancet Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for persistent candidemia and prognostic implications: Results from the ECMM Candida III study.
Sarah Sedik, Matthias Egger, Stella Wolfgruber, Jon Salmanton-García, Matteo Bassetti, Philipp Koehler

J Infect· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-COVID Fatigue Is Associated With Reduced Cortical Thickness After Hospitalization.
Tim J Hartung, Florentin Steigerwald, Amy Romanello, Cathrin Kodde, Matthias Endres, Philipp Koehler

Ann Clin Transl Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bjerkandera spp. Pulmonary Infection in Immunocompromised Hosts, Germany.
Rosanne Sprute, Danila Seidel, Katrin Mehler, Zoé Westhues, Sarina K Butzer, Philipp Koehler

Emerg Infect Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 2025 EQUAL Score-an ECMM tool to measure QUALity in pneumonia management.
Luise Haensel, Rosanne Sprute, Jan Grothe, Florence Robert-Gangneux, Jean-Pierre Gangneux, Philipp Koehler

JAC Antimicrob Resist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and treatment of invasive pulmonary aspergillosis in critically ill intensive care patients: executive summary of the German national guideline (AWMF 113-005).
Dominic Wichmann, Martin Hoenigl, Philipp Koehler, Christina Koenig, Frederike Lund

Infection· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards shorter therapy for candidaemia: defining uncomplicated candidaemia in adults.
Ilana Reinhold, Susanne Picardi, Blasius Liss, Danila Seidel, Jannik Stemler, Philipp Koehler

Lancet Infect Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM.
Oliver A Cornely, Rosanne Sprute, Matteo Bassetti, Sharon C-A Chen, Andreas H Groll, Philipp Koehler

Lancet Infect Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[S1 guideline: diagnosis and treatment of invasive pulmonary aspergillosis in critically ill/intensive care patients].
Dominic Wichmann, Martin Hoenigl, Philipp Koehler, Christina Koenig, Frederike Lund

Med Klin Intensivmed Notfmed· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating pre-test probability and β-D-glucan cut-offs to enhance accuracy in diagnosing pneumocystis pneumonia.
Luise Hänsel, Oliver A Cornely, Philipp Koehler

Clin Microbiol Infect· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies.
Michael Sandherr, Jannik Stemler, Enrico Schalk, Tessa Hattenhauer, Marcus Hentrich, Philipp Koehler

Lancet Reg Health Eur· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which trial do we need? Shorter antifungal treatment for candidemia - challenging the 14-day dogma.
Nico Bekaan, Oliver A Cornely, Tim Friede, Jürgen Prattes, Rosanne Sprute, Philipp Koehler

Clin Microbiol Infect· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic assessment of COVID-19 host genetics using whole genome sequencing data.
Axel Schmidt, Nicolas Casadei, Fabian Brand, German Demidov, Elaheh Vojgani, Philipp Koehler

PLoS Pathog· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection.
Joanne Byrne, Lili Gu, Alejandro Garcia-Leon, Colette Marie Gaillard, Gurvin Saini, Philipp Koehler

Front Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B).
Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, Kristin Greve-Isdahl Mohn, Antonio-José Carcas-Sansuan, Philipp Koehler

Int J Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study.
Jon Salmanton-García, Oliver A Cornely, Jannik Stemler, Aleksandra Barać, Jörg Steinmann, Philipp Koehler

J Infect· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
Jon Salmanton-García, Francesco Marchesi, Francesca Farina, Barbora Weinbergerová, Federico Itri, Philipp Koehler

EClinicalMedicine· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
Matteo Bassetti, Daniele R Giacobbe, Christina Agvald-Ohman, Murat Akova, Ana Alastruey-Izquierdo, Philipp Koehler

Intensive Care Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cologne ECMM Excellence Center: A Two-Year Analysis of External Consultation Service for Invasive Fungal Infections.
Jon Salmanton-García, Philipp Koehler, Jan-Hendrik Grothe, Sibylle C Mellinghoff, Ertan Sal

Mycopathologia· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Questioning the 14-day dogma in candidemia treatment duration.
Jon Salmanton-García, Ilana Reinhold, Juergen Prattes, Nico Bekaan, Philipp Koehler

Mycoses· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b safety and pharmacokinetics of intravenous and oral fosmanogepix in patients with acute myeloid leukaemia and neutropenia.
Oliver A Cornely, Helmut Ostermann, Philipp Koehler, Daniel Teschner, Endrik Limburg

J Antimicrob Chemother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1).
Julia M Neuhann, Jannik Stemler, Antonio J Carcas, Jesús Frías-Iniesta, Murat Akova, Philipp Koehler

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time.
Grace Kenny, Sophie O'Reilly, Neil Wrigley Kelly, Riya Negi, Colette Gaillard, Philipp Koehler

Nat Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis